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Abstract
In vivo models of cerebral hypoxia-ischemia have shown that neuronal death may occur via necrosis or apoptosis. Necrosis is,
in general, a rapidly occurring form of cell death that has been attributed, in part, to alterations in ionic homeostasis. In
contrast, apoptosis is a delayed form of cell death that occurs as the result of activation of a genetic program. In the past
decade, we have learned considerably about the mechanisms underlying apoptotic neuronal death following cerebral hypoxia-
ischemia. With this growth in knowledge, we are coming to the realization that apoptosis and necrosis, although
morphologically distinct, are likely part of a continuum of cell death with similar operative mechanisms. For example, following
hypoxia-ischemia, excitatory amino acid release and alterations in ionic homeostasis contribute to both necrotic and apoptotic
neuronal death. However, apoptosis is distinguished from necrosis in that gene activation is the predominant mechanism
regulating cell survival. Following hypoxic-ischemic episodes in the brain, genes that promote as well as inhibit apoptosis are
activated. It is the balance in the expression of pro- and anti-apoptotic genes that likely determines the fate of neurons exposed
to hypoxia. The balance in expression of pro- and anti-apoptotic genes may also account for the regional dierences in
vulnerability to hypoxic insults. In this review, we will examine the known mechanisms underlying apoptosis in neurons exposed
to hypoxia and hypoxia-ischemia. 7 2000 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Over the past decade, there has been a vast and
growing interest in the importance of the role of cell
death in normal biological processes, e.g., develop-
ment, and in pathologic conditions. In the 1970s, cell
death was ®rst classi®ed, based on histologic criteria,
as being necrotic or apoptotic. Since this early classi®-
cation, we have come to learn that these terms rep-
resent more than just morphologic descriptions but
rather distinct mechanisms leading to the histologic
®ndings observed. Furthermore, we have realized that
apoptosis is not necessarily a pathologic process. Thus,
whereas necrotic cell death is the consequence of a
pathologic event, apoptosis, in contrast, is most often
a developmental event that is critical in maintaining
organismal homeostasis. However, apoptosis can also
be activated in pathologic conditions as well. Apopto-
sis serves to remove cells from an organism in an
orderly, programmed fashion without inducing a
major in¯ammatory response. For example, apoptosis
plays an important role in the pathogenesis of a num-
ber of disease states including hypoxic-ischemic brain
injury. The subject of apoptosis has increased in depth
and breadth. We have learned considerably about
apoptosis in hypoxic/ischemic cell injury and death.
Since some of this work has been done in the central
nervous system, we focus in this review on some of the
salient mechanisms of apoptosis and some of the im-
portant genes that play a role in programmed cell
death. In particular, we review the underlying mechan-
isms that are critical to cell death in conditions of low
oxygen or low oxygen and substrate delivery in the
central nervous system.
1.1. Characteristics of necrosis and apoptosis
Necrosis is, in general, a form of cell death that
rapidly occurs in response to severe insults such as
anoxia and cell trauma. Typically, necrosis has been
associated with alterations in calcium and sodium ion
homeostasis. In contrast, apoptosis is a delayed form
of cell death that is the result of less severe insults and
is associated with activation of a ``genetic program''.
To help investigators distinguish necrosis from apopto-
sis, a number of criteria have been established that will
be discussed below. It is important to recognize that
this ``classical'' concept of cell death may not be com-
K.J. Banasiak et al./ Progress in Neurobiology 62 (2000) 215±249 216pletely accurate. Although necrosis and apoptosis are
morphologically distinct, it is becoming more evident
that necrosis and apoptosis are likely part of a conti-
nuum of cell death and similar mechanisms may be
operative in both processes.
1.2. Morphologic criteria of apoptosis
The earliest morphologic changes in cells undergoing
necrosis include cellular and organellar swelling, es-
pecially the mitochondria (Trump et al., 1982). Sub-
sequently, there is dissolution of organelles, rupture of
the plasma membrane with leakage of cellular contents
into the extracellular space, and random DNA degra-
dation following histone proteolysis. Necrosis usually
aects large groups of adjacent cells and is associated
with in¯ammatory reaction.
In contrast, cells undergoing apoptosis exhibit
shrinkage of the cytoplasm and condensation of
nuclear material into ``clumps'' (Wyllie, 1981; Walker
et al., 1988). As the process continues, the nucleus
undergoes fragmentation and the endoplasmic reticu-
lum fuses with the plasma membrane forming vesicles
and convoluting the surface of the plasma membrane.
In the ®nal stages of apoptosis, there is cellular frag-
mentation forming membrane-bound apoptotic bodies
that contain intact cytoplasmic organelles and nuclear
fragments.
There are several essential gross morphologic fea-
tures distinguishing necrosis from apoptosis. First,
apoptotic cells exhibit loss of cytoplasm while necrotic
cells have cytoplasmic swelling. Second, nuclear
changes precede plasma membrane changes in apopto-
sis while the reverse is observed during necrosis. Third,
apoptotic cells maintain plasma membrane integrity
while necrotic cells undergo plasma membrane rupture.
Because of the ability to clearly resolve these relatively
unequivocal morphologic dierences, electron mi-
croscopy is much preferred over light microscopy for
distinguishing apoptotic from necrotic cells.
1.2.1. DNA fragmentation
In necrotic cells, DNA undergoes random fragmen-
tation following histone proteolysis. Because histones
remain intact in apoptotic cells, DNA is cleaved into
multimers of 180±240 base pairs (Wyllie, 1980). In an
attempt to use this event as a means of distinguishing
necrotic from apoptotic cells, techniques for gel elec-
trophoresis of genomic DNA and in situ labeling of
DNA fragments were developed.
Typically, genomic DNA from necrotic cells exhibits
a single vertical band on electrophoresis (``smear pat-
tern''). In contrast, genomic DNA will exhibit a ``lad-
der pattern'' on electrophoresis. Because of potential
technical diculties, especially with DNA band resol-
ution, it is generally dicult to dierentiate these two
patterns.
In situ DNA fragmentation can be detected by one
of two methods. The ®rst is terminal deoxynucleotidyl
transferase nick end labeling (TUNEL) that involves
binding of dUTP tagged with a chromagen or ¯uoro-
phore to the 3'-OH ends of single or double-stranded
DNA (Gavrieli et al., 1992) The alternative method, in
situ end labeling, involves the addition of labeled
nucleotides to the 3' ends of oligonucleosomes with 5'
overhangs that serve as a template for DNA polymer-
ase I. Although these methods are quite sensitive for
detection of in situ DNA fragmentation, they cannot
dierentiate necrotic and apoptotic cells.
1.2.2. Annexin V
During the early phases of apoptosis, phosphatidyl-
serine is translocated from the inner surface to the
outer surface of the plasma membrane (Vermes et al.,
1995). It is believed that this translocation is a phylo-
genetically conserved process that serves as a marker
for phagocyte removal of cells (Meers and Mealy,
1993; Vermes et al., 1995). The calcium-dependent
phospholipid binding protein, annexin V, can bind to
phosphatidylserine after its translocation to the exter-
nal surface of the cell (Vermes et al., 1995). The use of
¯uorophore-tagged annexin and a membrane-excluded
dye, such as propidium iodide, provides a method of
detecting apoptotic cells. Apoptotic cells are typically
identi®ed by plasma membrane binding of the tagged
annexin V and exclusion of propidium iodide. Contro-
versy exists as to the interpretation of cells exhibiting
both annexin V plasma membrane binding and DNA
binding of propidium iodide. This pattern of staining
could either represent loss of plasma membrane integ-
rity in necrotic cells or cells in the latter stages of
apoptosis.
1.2.3. Choice of method
In situ DNA labeling and annexin V staining are
unable to unequivocally distinguish apoptosis from
necrosis. Because of its high resolution of the ultra-
structure of cells, electron microscopy is the generally
accepted ``gold standard'' for determining the presence
of apoptosis. However, electron microscopy does not
readily lend itself as a useful application for quantitat-
ive studies of cell death since investigators face a stat-
istical sampling problem. Based on our experience, we
believe that when performing quantitative apoptotic
studies, electron microscopy should be used to deter-
mine the presence of apoptosis in conjunction with
other methods (e.g., TUNEL, Annexin V) to quanti-
tate apoptotic cells.
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One of the commonly used models in vivo or in
vitro to further our understanding of O2 deprivation is
that involving the use of excitatory amino acids such
as glutamate and its receptor agonists. The idea is that
glutamate and its agonists, such as NMDA agonists,
mimic the eect of hypoxia or ischemia on neurons.
This idea gained popularity since glutamate is well
known to be released in high quantity at nerve term-
inals during hypoxia. However, it should be noted
that, on the one hand, hypoxia in¯uences many dier-
ent cellular processes that may be dierent from those
aected by glutamate. Hence, it is of no surprise that
when neurons are exposed to hypoxia, their response
in terms of intracellular Ca
2+ homeostasis and mor-
phology is very dierent from those that take place
after glutamate exposure, as previously illustrated by
work from our laboratory and those of others (Chihab
et al., 1998; Chow and Haddad, 1998). On the other
hand, it should be clear that the importance of the glu-
tamate model is not only related to models of hypoxia
and ischemia but also to those that stem from disease
processes that are presumably based on genetic patho-
physiologies or those that do pertain to redox or oxi-
dative states (Dubinsky, 1995). In this section, we will
focus on glutamate-induced cell death and detail some
of the other potential model systems for the sake of
comparison.
2.1. Glutamate and neuronal apoptosis
Some of the important ideas that, in a sense, delayed
our understanding of the long term eects of gluta-
mate on neuronal cell death and cell survival were re-
lated to the highly popular observations that neurons
die when exposed acutely to large amounts of gluta-
mate, as neurons are when deprived of O2 and nutri-
ents (Choi, 1987). Clearly, by the nature of these
experiments, long-term eects could not be easily ap-
preciated. It was not until the acute eects of gluta-
mate were blocked that the delayed cell death that
could be induced by glutamate was discovered (Gwag
et al., 1995; Choi, 1996; Figiel and Kaczmarek, 1997;
Portera-Cailliau et al., 1997; Nicotera et al., 1999). It
is the ``peeling'' of one set of mechanisms that made it
possible to more fully appreciate the extent of gluta-
mate excito-toxicity!
In the past 3±4 years, it has become clear that mod-
erate glutamate exposure over prolonged periods can
lead to apoptotic cell death in neurons. This has been
associated with a recovery in mitochondrial energy
function, unlike neurons dying acutely from massive
glutamate exposure in which ATP generation is elimi-
nated and mitochondrial function non-existent (Ankar-
crona et al., 1995). Of particular interest also are data
showing that nuclear disintegration and DNA single
strand-breaks are early events in granular cell apopto-
sis that precede any recognizable morphologic changes
in these neurons (Didier et al., 1996; Ikeda et al.,
1996). This has been clearly shown in culture and evi-
dence of apoptotic changes has been observed not only
after glutamate exposure but also after selective
AMPA receptor stimulation (Larm et al., 1997).
NMDA receptor stimulation can also be part of the
glutamate-induced apoptosis and the desensitization of
NMDA receptors is neuro-protective against apoptosis
that can occur with glutamate (Wood and Bristow,
1998). Furthermore, it has been suggested that lithium
protects against apoptosis by blocking NMDA-
mediated Ca
2+ ¯ux into neurons (Nonaka et al.,
1998). Recently, however, another interesting obser-
vation, seemingly opposite to previous observations,
was published: blockade of NMDA receptors led to
apoptosis and neuro-degeneration in fetal and neonatal
rat brain (Ikonomidou et al., 1999). This is suggestive
of the concept that the concentration of glutamate or
glutamate receptor agonists is crucial in bringing
about a survival or an injury signal whether apoptotic
or necrotic in nature. Therefore, it is possible that a
certain amount of glutamate ``protects'' against apop-
tosis and its removal is deleterious and large amounts
of glutamate may also be injurious to nerve cells, with
a delicate balance being optimal for neuronal growth
and integrity. Whether this type of injury resulting
from excess glutamate is similar to other types of
apoptotic cell death in terms of mechanisms (e.g.
apoptosis by serum deprivation) is not understood at
present (MacManus et al., 1997; Manev et al., 1997;
Piantadosi et al., 1997; Ohgoh et al., 1998).
2.2. Mechanisms of glutamate-induced apoptosis
There are various mechanisms and biochemical
events that have been implicated in the glutamate-
induced apoptotic changes. In the past 2±3 years, it
has been shown that the mitochondria is central in glu-
tamate-induced cell death (Montal, 1998). For
example, calcineurin inhibition, a calcium-calmodulin-
regulated phosphatase, prevented the collapse of mito-
chondrial membrane potential and apoptotic cell death
(Ankarcrona et al., 1996; Wang et al., 1999a, 1999b).
The way calcineurin works is that it dephosphorylates
BAD, a pro-apoptotic gene product, which is then
translocated to the mitochondria to dimerize with Bcl-
xl, a process that initiates apoptosis (Fig. 1; Wang et
al., 1999a, 1999b). It is this dimerization that induces
the release of cytochrome c from mitochondria and,
along with Apaf-1 and pro-proteases (see below), pro-
teases are formed and lead the way to cell death by
apoptosis (Neame et al., 1998).
Whereas BAD can initiate apoptosis, it is well recog-
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serine and cysteine proteases. The latter are termed
caspases and have been extensively studied and found
to be important in mediating apoptotic events (Du et
al., 1997; Gottron et al., 1997; Leist et al., 1997; Ten-
neti et al., 1998). More recently, caspase-3, one of the
major ones, has been linked to cell death induced by
glutamate and its receptors and glucose/O2 deprivation
(Du et al., 1997; Gottron et al., 1997; Leist et al.,
1997; Tenneti et al., 1998). The transcription factor
AP-1 and c-Jun activation by its kinase Jnk, especially
Jnk-3, which is selectively expressed in the CNS, is
also critical as a Jnk-3 knock-out protected mice from
excito-toxic induced apoptosis (Tabuchi et al., 1996;
Yang et al., 1997a, 1997b; Cheung et al., 1998). Gluta-
mate-induced apoptosis also can activate another path-
way, that of p53, a tumor suppressor gene, that can
lead to cell death by activating Bax-related pathway in
neurons (Fig. 1; Uberti et al., 1998; Xiang et al.,
1998). Hence, glutamate can lead to apoptosis by acti-
vating a number of processes that possibly converge
into caspase activation. While it is not clear yet as to
what are the gene products that constitute all the tar-
gets for caspases, it is clear now, from the preceding
discussion, that caspases play a very important role in
activating cell death by apoptosis when neurons are
exposed to increased levels of glutamate or hypoxia/
ischemia.
Reactive oxygen species (ROS) have also been well
known to induce cell death by either necrosis or apop-
tosis (Tan et al., 1998; Carmody et al., 1999; Davis
and Johnson, 1999). Antioxidants that scavenge ROS
inhibit apoptosis in a number of diseases and patho-
physiological conditions (Tan et al., 1998; Carmody et
al., 1999; Davis and Johnson, 1999). Examples abound
for neurologic diseases such as in Alzheimer's disease,
Parkinson's disease and retinitis pigmentosa and
photoreceptor degeneration (Merad-Boudia et al.,
1998). One interesting recent study has demonstrated
also that, while Ca
2+ in¯ux and collapse of the mito-
chondrial membrane potential are early events (Nico-
tera and Rossi, 1994; Takei and Endo, 1994; Wei et
al., 1998; Mason et al., 1999), preceding caspase acti-
vation, ROS formation and lipid peroxidation are
likely downstream events of caspase activation and
may be targets of caspase action.
3. Energy-deprivation and apoptosis
Oxygen deprivation will lead naturally to energy
deprivation and the question that arises is whether
energy metabolism is linked to apoptotic cell death.
While the mitochondrion is certainly central to apop-
tosis, ATP and energy metabolism is not necessarily
and clearly involved. Furthermore, if metabolism is
involved, how is it and whether this involvement is
direct through ATP or not is not clearly shown in
Fig. 1. Mechanisms of glutamate-induced apoptosis. Activation of calcineurin, a calcium-calmodulin-regulated phosphatase, by glutamate recep-
tor activation, allows calineurin to dephosphorylate bad. The dephosphorylated form of bad is then translocated to the mitochondrial membrane,
where it binds to either bcl-xl or bcl-2. Formation of these heterodimers induces release of cytochrome c from the mitochondria, leading to cas-
pase activation. Alternatively, glutamate can activate bax in a p53-mediated process. With increased protein levels, bax homodimers are formed
and contribute to protease activation.
K.J. Banasiak et al./ Progress in Neurobiology 62 (2000) 215±249 219neurons. There are observations in the literature, actu-
ally, that show that ATP levels may be at control
levels during apoptosis (Davis and Johnson, 1999). Of
interest also is that phosphate incorporation into ATP
and the Na
+-dependent phosphate entry into cells is
markedly decreased in cells (Davis and Johnson, 1999).
However, phosphorylation of certain proteins can cer-
tainly be increased during apoptosis. This generalized
decrease in ATP phosphate incorporation and trans-
port in the presence of increased selective phosphoryl-
ation is consistent with the concept that we put
forward previously regarding the presence of a cellular
``hierarchy'' which determines the ``use'' or distribution
of a variety of moieties, including amino acids and
phosphate moieties (Ma and Haddad, 1997).
4. Ionic mechanisms and neuronal apoptosis
Although intracellular calcium ions, Cai
2+, have
been known to be associated with intracellular signal-
ing, with activation of a variety of enzymes and with
gene activation (Nicotera et al., 1994; Santella and
Carafoli, 1997), other ions such as Na
+ and K
+ have
not until recently. In addition, more work has been
done fairly recently on intranuclear Ca
2+ (Santella
and Carafoli, 1997; Scotto et al., 1998) and its relation
with apoptotic and anti-apoptotic genes. Below, we









i has long been known to be involved in neur-
onal cell injury, mostly due to the discoveries over the
past two decades related to glutamate, its eects on
neuronal cell death and its simultaneous eect on Ca2
i
regulation. In the past 4±5 years, however, Ca2
i has
been demonstrated to be associated with apoptotic cell
injury. For example, Ca
2+ ionophores (e.g., ionomy-
cin) induce ultra-structural changes of cell body
shrinkage, compaction of the nucleus with chromatin
condensation and DNA fragmentation that are con-
sistent with an apoptotic process in rat cortical neur-
ons (Takei and Endo, 1994; Wei et al., 1998; Mason et
al., 1999). Furthermore, in this model, apoptosis is as-
sociated with transcription and translation, since RNA
and protein synthesis inhibitors eliminate cell death.
Presumably, Ca
2+ is entering from the outside to
inside the cell with ionomycin. This work on cortical
neurons was also recently supported by work on cer-
ebellar granular cells in which dihydropyridine Ca
2+
channel blockers (e.g. amlodipine) may have a neuro-
protective eect by the attenuation of Ca2
i induced by
KCl depolarization (Takei and Endo, 1994; Wei et al.,
1998; Mason et al., 1999).
The role of Ca2
i does not have to be related to the
in¯ux of Ca
2+ from the outside of cells. Indeed, the
overexpression of bcl-2, an anti-apoptotic oncogene,
protects against the eect of thapsigargin-induced
apoptosis (Takei and Endo, 1994; Wei et al., 1998;
Mason et al., 1999). Although thapsigargin increases
cytosolic Ca
2+, bcl-2 did not alter Ca
2+, thus casting
some doubt on the idea that bcl-2 protects neurons by
altering Ca
2+ regulation.
While an increase in Ca2
i may be involved in indu-
cing an apoptotic process, the events that lead to cell
death are far from being understood. A number of
possible Ca
2+ involvements have been considered. For
instance, the release of caspase-9 from the mitochon-
dria and its accumulation in the cell nucleus with sub-
sequent apoptosis, a bcl-2 inhibitable process, can be
triggered by extra-mitochondrial Ca
2+ (Walker et al.,
1994a, 1994b; Juin et al., 1998; Krajewski et al., 1999).
Interestingly, bax has a similar eect as Ca
2+ in this
model system and in activating caspase-9. Another
cytosolic eect of Ca
2+ has recently been shown to be
linked to the activation of caspase-3 and that the in-
hibitors of the latter obliterate the eect of Ca
2+ in a
cell-free model (Walker et al., 1994a, 1994b; Juin et
al., 1998; Krajewski et al., 1999).
Other possible pathways for the role of Ca
2+
involve intranuclear levels and the potential inter-
actions of Ca
2+ with DNA and genes. Indeed, intra-
nuclear Ca
2+ ¯uctuations have been shown to aect
chromatin organization, induction of genes and the ac-
tivation of DNA cleavage by the activation of endonu-
cleases (Walker et al., 1994a, 1994b; Juin et al., 1998;
Krajewski et al., 1999). These types of studies have
highlighted the importance of the regulation of ionic
¯ux through the nuclear envelope since these control
mechanisms will have major implications on Ca
2+ or
other ionic transport to the nucleus. Ca
2+ pumps,
Ca
2+ channels and inositol-triphosphate channels have
been found in the nuclear envelope and most likely
participate in Ca
2+ homeostasis across the nucleus.
Although a number of biochemical reactions take
place in the nucleus involving Ca
2+, some of these are
dependent on calmodulin-dependent kinases and phos-
phatases. Independent of these calmodulin-dependent
processes, apoptosis can take place and the role of
Ca
2+ in the nucleus does not not need to involve cal-
modulin (Takei and Endo, 1994; Walker et al., 1994a;
Walker et al., 1994b; Juin et al., 1998; Wei et al., 1998;
Krajewski et al., 1999; Mason et al., 1999).
4.2. Potassium ions
A relatively newer area of research is the relation
between K
+ channels and apoptosis or proliferation of
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astrocytoma cell lines (Chin et al., 1997). Blockers (e.g.
4-aminopyridine) of speci®c K
+ channels, such as an
outward recti®er, stopped the proliferation of this cell
line and induced apoptosis. These investigators were
not successful with other blockers such as charybdo-
toxin, which generally blocks the Ca
2+-sensitive, large
and voltage-dependent K
+ channel (Chin et al., 1997).
In a dierent model system, that of apoptosis
induced by serum deprivation or by staurosporine,
Choi and colleagues also found out that K
+ channels
are causally linked to apoptosis (Yu et al., 1997), albeit
their results were not consonant with those in the
astrocytoma lines. In brief, these studies showed an
enhancement, rather than an inhibition, of an outward
K
+ current with serum deprivation, which led to
apoptosis. An increase in extracellular K
+, which
should lower the driving force for K
+ eux, or tetra-
ethylammonium, which blocks K
+ channels, showed
attenuation of apoptosis (Yu et al., 1997). Two points
can be made regarding these studies: (a) It is not clear
whether the dierence obtained is related to the
models of apoptosis or whether it is related to the
nature of the tissue used; and (b) whether multiple K
+
channels can participate dierently in apoptosis
depending on the environmental conditions. More
recently, the same group of investigators has shown
that the outward K
+ current that ensues from N-
methyl-D-aspartate receptor activation plays a role in
inducing apoptotic changes in hippocampal neurons in
culture (Yu et al., 1999).
If K
+ channels are involved in a cascade of events
that lead to apoptosis, do we know about these events
in cells undergoing apoptosis? This cascade is poorly
understood at present. However, there is some infor-
mation related to this question. For example, the non-
receptor tyrosine kinases, the Src family, seem to have
as a target the activation of the delayed recti®er K
+
channels (Sobko et al., 1998), channels that have been
incriminated in inducing apoptosis and in curbing pro-
liferation when they are opened in neuronal culture.
The importance of the link between the Src family and
the delayed recti®er K
+ channels is that this work is
related to the onset of myelination and proliferation of
Schwann cells. Hence, the inhibition of the Src family
and the block of these channels may be relevant to the
initiation of myelination.
Another possible pathway is that of growth factors
and cytokines which have K
+ channels as one of their
important downstream eectors. In cultured oligoden-
drocytes, ceramide, a lipid mediator induced by cyto-
kines and which can by itself lead to apoptosis,
depolarizes these cells by blocking inward recti®er K
+
channels via a Ras or a raf-1 pathway. Therefore, it is
likely that in these cells, upon the release of pro-in-
¯ammatory cytokines, ceramide activates a phos-
phorylation process, which blocks these K
+ channels
and leads to apoptosis. In this scenario, a block in K
+
channels leads to apoptosis (Hida et al., 1998). What
is not clear from this work is whether the depolariz-
ation is needed to reach apoptosis in oligodendrocytes.
Other workers in the ®eld have studied this question
from a dierent angle. Since (a) gene products like
reaper, grim and hid have been shown to induce apop-
tosis in Drosophila (Chen et al., 1996a, 1996b; Avdonin
et al., 1998; Wing et al., 1998) and (b) these proteins
have an N-terminus that has some homology to the N-
terminal portion of K
+ channels that plays an import-
ant role in K
+ channels inactivation, these were
expressed in oocytes and examined for the inactivation
of K
+ channels. They found that both reaper and
grim do inhibit these particular channels, but hid did
not (Chen et al., 1996a, 1996b; Avdonin et al., 1998;
Thress et al., 1998; Vucic et al., 1998; Wing et al.,
1998). There are several potential problems with these
studies. First, if these are pro-apoptotic genes, one
could ask as to why is it that one of the three gene
products tested (i.e., hid) does not inhibit a process,
like the other two products? Second, the rationale for
testing these proteins is not very convincing since the
homology is poor and this homology is in the ®rst 6
amino-acid region of the DNA which does not confer
inactivation of the K
+ channels. Third, in this model,
these gene products inhibit K
+ channels and do not
enhance their activity, unlike other intermediates of
apoptosis in which K
+ channel activation leads to cell
death. Furthermore, what is unclear at present is the
sequence of events that is induced by these gene pro-
ducts and whether K
+ channels are in that sequence.
Also, since reaper induces the release of cytochrome c
and activates caspases, the relation between K
+ chan-
nels and caspases or mitochondrial function is not well
understood.
Of interest are recent reports demonstrating that K
+
channel activation is of functional importance in apop-
tosis of disease states. For example, these K
+ channels
were shown to be involved in linking beta-amyloid of
Alzheimer's disease and the induced apoptosis in neo-
cortical neurons (Colom et al., 1998; Yu et al., 1998).
These studies used in-vitro models and showed that
the delayed recti®er K
+ channel activation was central
to the induction of apoptotic cell death. Other K
+
channels were not involved in amyloid-induced apop-
tosis and the delayed recti®er K
+ channels were not
involved in cell death induced by other means. Fur-
thermore, K
+ channel activation seems also to mediate
cell death of myeloblastic leukemia cells when exposed
to U-V irradiation (Wang et al., 1999a, Wang et al.,
1999b). The activation of K
+ channels in this latter
model were important for the activation of speci®c
kinases, such as c-Jun kinase and SAP kinase, which
were central to the induction of apoptosis; and the in-
K.J. Banasiak et al./ Progress in Neurobiology 62 (2000) 215±249 221hibition of K
+ channels prevented the activation of
these kinases. Also worthy of investigation is the re-
lation of hypoxia-induced K
+ channel activation or in-
activation and their relation to apoptosis.
4.3. Sodium ions
While a number of investigations have focused their
attention on the importance of Ca2
i in cell death in
general, little attention has been paid to the role of
Na
+ in neuronal injury, let alone apoptosis. Several
years ago, it became clear to us that intracellular Na
+
Na
i  increases during O2 deprivation (Friedman and
Haddad, 1994a, 1994b) and played an important role
in the acute depolarization that is induced by hypoxia
(Haddad and Jiang, 1993). Furthermore, preventing
the increase in Ca2
i during hypoxia had no eect on
cell injury and cell death (Friedman and Haddad,
1993). Therefore, there were two important questions
at that juncture: (a) Does Na
i play a role in cell injury
during O2 deprivation and (b) more speci®cally, does
Na
i play a role in inducing apoptosis when the hy-
poxic stress is prolonged? Both of these questions are
not resolved at this time but there is increasing evi-
dence that Na
i plays an important role in cell death.
We will mostly address the second question in this sec-
tion. However, there are very few studies on neurons
and most investigations in this area are performed on
non-neuronal cells.
Recent work on apoptosis in lymphocytes has
shown that, as has been the case for other cells, apop-
tosis is associated with cell shrinkage and indeed this is
one morphologic criterion often used for separating
apoptosis from necrosis (Bortner et al., 1997). What is
interesting in this study was that the cell shrinkage
seen was associated with a loss of ionic strength and
loss of both intracellular Na
+ and K
+ measured by
¯ow cytometry and optically (Bortner et al., 1997).
This study did not address, however, the importance
of each individual ion per se and did not consider the
role of Na
+ separately (Bortner et al., 1997). Very
recently, the ratio of Na
+/K
+ was investigated in vas-
cular smooth muscles (Orlov et al., 1999). In a model
of apoptosis induced by serum deprivation or stauros-
porine, changing the ratio of Na
+/K
+ from a low one
to a higher one (with the use of ouabain) prevented
the occurrence of apoptosis. Activation of caspase-3
and the fragmentation of chromatin, which were as-
sociated with this model, did not occur when ouabain
was used to increase the ratio of Na
+/K
+ and inhibit
apoptosis. Hence, at rest in these smooth muscle cells,
the ratio of these ions is such that cells are primed to
undergo apoptosis if the appropriate triggers are pre-
sent.
Clearly, there are a number of membrane proteins
that control ionic ¯ux at rest and during O2 depri-
vation. In the recent past, there has been some work
examining the importance of some of these proteins in
cell death. For example, in experiments on smooth
muscle lines that are de®cient in Na/H exchanger
(NHE), it was found that these cells do not grow and
proliferate in HCOÿ
3 -free solutions but they do grow
when they were transfected back with the exchanger
(Takahashi et al., 1995). In addition, inhibition of the
exchanger with the HOE694 blocker also inhibited cell
growth (Takahashi et al., 1995). It is of interest, pro-
liferation of pulmonary vascular smooth cells during
hypoxia is dependent on NHE (Takahashi et al.,
1995).
Of major relevance to this chapter is work that
has been recently performed during ischemia on car-
diac myocytes (Chakrabarti et al., 1997). Apoptosis
in such cells (assayed by the TUNEL method)
resulting from ischemia was inhibited with the use of
HOE642, another inhibitor of NHE. These results
on cardiac myocytes contrast, therefore, with results
of other studies noted above and it is not clear at
present what the role of NHE is in cell death at rest
and during stress, and in particular during hypoxia
and ischemia.
Other studies (Perez-Sala et al., 1995; Reynolds et
al., 1996; Furlong et al., 1997; Schlesinger et al.,
1997; Shimizu et al., 1998; Park et al., 1999) have
focused on pHi regulation and the relation between
pHi and apoptosis. It seems that a decrease in pHi pre-
cedes caspase activation and that an attenuation of
this decrease in pHi can reduce apoptosis and caspase
activity (Furlong et al., 1997). Although there are a
number of mechanisms and transporters that can aect
pHi regulation, an important one is NHE. How NHE
relates to apoptosis is not clear except that the inhi-
bition of NHE by amiloride derivatives can block the
protective eect of certain cytokines (IL-3, and GM-
CSF) in cell lines in which early intracellular acidi®ca-
tion precedes apoptosis. Similarly, intracellular alkali-
nization via increased activity of NHE in a leukemic
cell line can suppress apoptosis (Perez-Sala et al.,
1995). The inhibition of apoptosis has been shown in
this model to be related to the inactivation of endonu-
cleases responsible for DNA degradation (Perez-Sala
et al., 1995).
5. Neurotrophic factors and neuronal apoptosis
Neurotrophic factors include a large family of tar-
get-derived proteins that play an important role in the
regulation of neuronal life and death. This is true for
both the central and peripheral nervous systems, es-
pecially during brain development and under patholo-
gic conditions such as hypoxia-ischemia.
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neuronal death
A previously held view is that naturally occurring
neuronal death depends simply on the absence of
appropriate survival signals such as neurotrophic fac-
tors. In the past decade, numerous neurotrophic fac-
tors and their mechanisms of action have been
elucidated and this has greatly improved our under-
standing of the role of neurotrophic factors in neur-
onal survival and death. Current literature has shown
that, on the one hand, neuronal survival depends on
neurotrophic factors; insucient amounts of such neu-
rotrophic factors can lead to cell death. For example,
nerve growth factor (NGF), neurotrophin-3 (NT-3),
and neurotrophin-4 (NT-4) are essential for survival of
sympathetic neurons during development (Levi-Mon-
talcini and Booker 1960; Li and Bernd, 1999; Levi-
Montalcini and Angeletti, 1966; Chun and Patterson,
1977; Johnson et al., 1983; Lindsay, 1988; Martin et
al., 1988; Ruit et al., 1990; Snider, 1994; Belliveau et
al., 1997; Bamji et al., 1998; Sondell et al., 1999). On
the other hand, some of these neurotrophic factors
such as BDNF (Bamji et al., 1998) can mediate apop-
totic signals and thus facilitate neuronal apoptosis.
Therefore, naturally occurring neuronal death is deter-
mined by the balance of survival and apoptotic signals
elicited by a variety of trophic factors (Bamji et al.,
1998; Behrens et al., 1999).
5.2. Role of neurotrophic factors in hypoxic/ischemic
apoptosis
Several lines of evidence have suggested that neuro-
trophic factors are up-regulated in the nervous system
and are involved in hypoxic/ischemic cascades (Kiyota
et al., 1991; Boniece and Wagner, 1993; Cheng and
Mattson, 1991; Zhang et al., 1993; Mattson and
Sche, 1994; Pechan, 1995; Sza¯arski et al., 1995; Bos-
senmeyer-Pourie et al., 1999; DeCoster et al., 1999;
Rong et al., 1999). In response to hypoxic-ischemic
stress, neurotrophic factors may regulate neuronal sur-
vival and death in two ways: (a) direct participation in
pathophysiological cascades and neuronal apoptosis
and (b) activation of inhibitory mechanisms of neur-
onal apoptosis. For example, there is evidence showing
that BDNF expression increases in adult rat forebrain
following limbic seizures (Cheng and Mattson, 1994;
Mitchell et al., 1999; Nitta et al., 1999). Since BDNF
may activate apoptotic signals, it is possible that the
increased BDNF expression is one of the mechanisms
underlying epileptic neuronal loss. Indeed, a number
of neurotrophic factors have shown a protective role
in neuronal apoptosis under pathological conditions.
For instance, delivery of ciliary neurotrophic factors
(CNTF) into the immediate vicinity of damaged neur-
ons or directly on cut axonal ends can increase neur-
onal survival (Sendtner et al., 1991; Hagg and Varon,
1993). Other experiments showed that NGF, CNTF,
and glial growth factor block apoptosis in neuronal
and glial supporting cells of the central and peripheral
nervous system (Louis, 1993; Grombacher, 1995;
Trachtenberg, 1996).
5.3. Mechanism of neuronal apoptosis: neurotrophic
factors and receptors of TrkA and p75
The eects of various neurotrophic factors are
mainly mediated by two dierent cell surface receptors:
TrkA and p75. The former mediates a neuronal survi-
val signal and the latter, an apoptotic signal.
TrkA is a member of the TrK family of receptors.
Binding to TrkA receptors is essential in neurotrophic
factor-mediated neuronal survival. A number of stu-
dies have shown that NGF binding to TrkA alone is
sucient to mediate many of the prototypic biological
responses elicited by NGF, including neuronal survival
and growth (Ibanez et al., 1992). Other experiments
have demonstrated that NT-3 and NT-4 activate TrkA
receptors to mediate neuronal survival, albeit less eec-
tively than NGF (Belliveau et al., 1997). In contrast,
BDNF, which does not elicit neuronal survival, does
not activate Trk receptors. These data strongly suggest
that activation of TrkA receptors is an important cel-
lular process for neurotrophic factors to promote neur-
onal survival and suppress neuronal apoptosis.
The p75 (p75
NTR) is a receptor which can interact
with most mammalian neurotrophic factors (Johnson
et al., 1986; Levi-Montalcini, 1987; Radeke et al.,
1987; Barde, 1989; Snider, 1994; Casaccia-Bonne®l et
al., 1999; Roux et al., 1999). The p75
NTR signal med-
iates apoptosis. When neurotrophic factors bind to
p75
NTR, a series of cellular processes are stimulated
such as generation of ceramide, activation and translo-
cation of NF-kB to the nucleus and enhancement of
Jun kinase (Jnk) activity which lead to neuronal apop-
tosis. In BDNF
ÿ/ÿ mice, neuronal number is larger as
compared to BDNF
+/+ littermates (Bamji et al.,
1998). In p75
NTRÿ/ÿ mice, the developmental period
that normally precedes neuronal death and which
occurs between birth and postnatal day 22, does not
take place. In addition, cultured p75
NTRÿ/ÿ neurons
died much more slowly than their wild type counter-
parts in the absence of NGF. Therefore, p75
NTR recep-
tor activation seems to be essential for neuronal
apoptosis. It is important to note that (a) most neuro-
trophic factors can interact with both TrkA and
p75
NTR receptors and (b) both TrkA and p75
NTR
receptors are important for the optimal development
of the CNS. For example, during neuronal develop-
ment, target-derived NGF may, in conjunction with
other neurotrophic factors, activate TrkA and p75
NTR
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neurons that fail to sequester adequate target territory.
In summary, neurotrophic factors are actively
involved in neuronal survival and apoptosis during
brain development and with environment stress. Their
survival and apoptotic signals are mediated mainly by
TrkA and p75
NTR receptors, respectively. The balance
of these two signaling pathways dictate neuronal survi-
val or apoptosis. Since most neurotrophic factors can
interact with both types of receptors, the net outcome
of neurotrophic stimulation depends on multiple fac-
tors including neuronal status, the level of neuro-
trophic agents, the ratio of neurotrophic factors,
developmental stage, and environmental conditions
(e.g., hypoxic severity and duration).
6. Regulation of hypoxia-induced neuronal apoptosis
In this section, we ®rst present some of our under-
standing of the genes important in regulating apoptotic
cell death. We then present a summary of the role of
theses genes in hypoxia-induced apoptotic cell death in
neurons. In some instances, we will use non-neuronal
examples to illustrate the role of some of these genes
in order to strengthen the discussion of the issues
raised.
6.1. Immediate-early genes
The immediate early genes (IEGs) represent a family
of over 100 genes that are induced within minutes to
hours following a variety of stimuli. These are termed
``immediate-early'' because they are induced in the
absence of de novo protein synthesis. The IEGs code
for a variety of proteins including secreted proteins
(e.g., cytokines), cytoplasmic enzymes (e.g., Cox-2),
ligand-dependent transcription factors (e.g., NGFI-B),
and inducible transcription factors (e.g., jun, fos) (Her-
degen and Leah, 1998). Because most current literature
on immediate-early gene expression following hypoxia-
ischemia focuses on the inducible transcription factors,
the following discussion will center on the functions of
this particular subfamily of IEGs.
The immediate early genes, c-fos, fosB, c-jun, junD,
krox-20, krox-24, NGFI-B Nurr77/TIS1, and NGFI-C
are oncogenes and related genes that produce nuclear
proteins functioning as transcriptional activators of
other genes. The exception is junB, which is ineective
in activating other promoters and likely functions as a
negative regulator of DNA binding and transcriptional
activation by c-fos, c-jun and junD (Chiu et al., 1988,
1989; Schutte et al., 1989; Ryseck and Bravo, 1991;
Baker et al., 1992; Nikolakaki et al., 1993). The tran-
scriptional activity of IEGs is regulated by phosphoryl-
ation by a number of protein kinases. For example,
phosphorylation of the C-terminus by either casein
kinase II or glycogen synthase kinase-3 inhibits c-jun
DNA binding and transcriptional activity (Lin et al.,
1992). In contrast, phosphorylation of c-jun and junD
by the stress activated protein kinases (SAPKs; also
known as jun kinases or JNKs) enhances transcrip-
tional activity forming a unique signal transduction
pathway important in the genesis of apoptosis (Hibi et
al., 1993; Derijard et al., 1994; Kyriakis et al., 1994;
Minden et al., 1994; Herdegen and Leah, 1998).
The IEG proteins not only function directly as tran-
scriptional activators but also form heterodimers alter-
ing the DNA binding properties and transcriptional
activity of a number of proteins. Heterodimerization
of c-jun with c-fos and the binding of the resulting
dimer to the DNA consensus sequence, TGACTCA,
forms the AP-1 transition complex that functions as a
transcriptional activator (Angel et al., 1987; Chui et
al., 1988; Sassone-Corsi et al., 1988; Sonnenberg et al.,
1989). AP-1 DNA-binding is enhanced in response to
apoptotic stimuli but its function remains unclear. C-
fos and c-jun also enhance transcription of a variety of
other transcription factors. C-jun, fra-1,a n dfra-2
function to repress transcription factor activity
through inhibition of DNA binding or inhibition of
transcription factor activation (Metz et al., 1994). Jun-
D is believed to enhance transcription factor activity
by preventing degradation of its partner protein
(Kovary and Bravo, 1991; Herdegen and Leah, 1998).
Rapid induction and transcriptional activation of
IEGs occur in response to phenomena observed fol-
lowing hypoxic-ischemic brain injury including electri-
cal depolarization, increased intracellular calcium,
excitatory amino acid exposure, and oxygen free rad-
ical exposure (Greenberg et al., 1985, 1986; Curran
and Morgan, 1986; Morgan and Curran, 1986; Sagar,
1988; Sheng et al., 1988). Following an hypoxic-
ischemic insult, immediate early gene expression occurs
in two phases. In the ®rst phase, occurring within 24 h
of the insult, there is an increase in c-fos, fosB, c-jun,
junB, junD, NGFI-A, and krox24 and increased AP-1
binding activity in the infarct and surrounding regions
(Dragunow et al., 1994; Hughes et al., 1998; Walton et
al., 1999). In the second phase, occurring 24±48 h fol-
lowing the injury, there is a persistent elevation of
fosB, c-jun, NGFI-A, and NGFI-C and a decrease in
krox24 (Dragunow et al., 1993, 1994; Hughes et al.,
1998; Walton et al., 1999). The IEGs induced follow-
ing hypoxia-ischemia may transcriptionally activate a
number of genes encoding structural proteins,
enzymes, ion channels, or neurotransmitters resulting
in long-lasting changes in neuronal structure and func-
tion (Table 1; Hughes and Dragunow, 1995). However,
it remains unclear as to whether these changes in IEG
expression promote or inhibit apoptosis in neurons. It
seems that IEGs likely serve to both inhibit and pro-
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modi®cation, such as phosphorylation by jun kinases,
or interaction with other proteins.
6.2. Bcl-2 and related proteins
The bcl-2 family is a growing group of proteins reg-
ulating cell death (Table 2). To date, more than 15
bcl-2 family members have been identi®ed (Chao and
Korsmeyer, 1998). Each member of this gene family
contains one or more of four conserved regions,
known as the bcl-2 homology domains (BH1±BH4),
that control the ability of these proteins to dimerize as
well as to regulate apoptotic cell death (Sato et al.,
1994; Sedlak et al., 1995). Bcl-2 family members that
inhibit apoptosis contain at least both the BH1 and
BH2 domains (Yin et al., 1994; Chittenden et al.,
1995a, 1995b; Muchmore et al., 1996). These bcl-2
proteins have also been divided into two groups based
on their structural domains: (a) those that are structu-
rally similar to bcl-2 and possess the BH1, BH2, and
BH3 domains such as Bax, Bak, and Bok and (b)
those that only possess the BH3 domain such as EGL-
1 (Chittenden et al., 1995a, 1995b; Cosulich, 1997).
6.2.1. Bcl-2 and Bcl-xl
Bcl-2 is the ®rst of a growing family of regulators of
apoptosis that was initially discovered in the t(14:18)
chromosomal breakpoint found in B-cell lymphomas.
(Bakhshi et al., 1985; Cleary and Sklar, 1985; Tsuji-
moto and Croce, 1986). In comparison to other onco-
proteins, bcl-2 is unique in that it promotes cell
survival rather than cell proliferation and this is
achieved via inhibition of apoptosis in multiple cell
types, including neurons. Bcl-xl represents one of three
known splice variants of the bcl-x gene product (Boise
et al., 1993; Gonzalez-Garcia et al., 1995; Ban et al.,
1998). Bcl-xl is similar in size and structure to bcl-2
Table 1
Genes transactivated by immediate early genes
a
Gene Mechanism(s) of action
Transin Encodes ametalloproteinase
Peripherin Encodes a neuronal speci®c ®lament protein
SCG10 Encodes a vesicle associated protein
GADD45 Binds to PCNA; inhibits cell cycle progression; facilitates DNA repair
NF-L, NF-M Encode neuro®lament subunits
41A, 41C Encode calcium binding proteins
NCAM Encodes neural cell adhesion molecule
Prodynorphin Encodes a proenkephalin (opioid precursor)
Nerve growth factor (NGF) Encodes a neurotrophic factor
Tyrosine hydroxylase Encodes a regulatory enzyme
a References: Sheng and Greenberg, 1990; Morgan and Curran, 1991; Hughes and Dragunow, 1995.
Table 2
Mechanism(s) of action of bcl-2 family members
a
Gene Function Mechanism(s) of Action
bcl-2 Anti-apoptotic Inhibits mitochondrial permeability transition; heterodimer formation with pro-
apoptotic proteins; inhibition of ROS generation; regulation of Ca
2+ ¯ux;
regulation of intracellular pH
bcl-xl Anti-apoptotic inhibits mitochondrial permeability transition; heterodimer formation with pro-
apoptotic proteins
bag-1 Anti-apoptotic Enhances raf-1 kinase activity; stimulate Hsc70 and Hsp70 ATPase activity
BI-1 Anti-apoptotic Interacts with bcl-2 and bcl-xl to inhibit bax activity
b¯-1 Anti-apoptotic Inhibits p53- and TNF-mediated apoptosis; cell cycle regulation
boo Anti-apoptotic Complexes apaf-1 and caspase-9
bcl-w Anti-apoptotic Unknown
bax Pro-apoptotic Promotes mitochondrial permeability transition
bak Pro-apoptotic Promotes mitochondrial permeability transition; heterodimer formation;
bad Pro-apoptotic Heterodimer formation; ceramide generation
bid Pro-apoptotic Induces structural change in bax
bim Pro-apoptotic Microtubule binding
diva Pro-apoptotic Binds to Apaf-1
bcl-xs, blk, bod, bok, btf, hara-kiri Pro-apoptotic Unknown
a References: see text for references.
K.J. Banasiak et al./ Progress in Neurobiology 62 (2000) 215±249 225and, like bcl-2, functions as a suppressor of apoptosis
(Chao et al., 1995).
bcl-2 and bcl-xl are complex proteins localized to
the membranes of the endoplasmic reticulum, nuclear
envelope and the outer mitochondrial membrane
(Hockenbery et al., 1990; Monaghan et al., 1992; Kra-
jewski et al., 1993; Hsu et al., 1997a, 1997b) indicating
that these proteins may play a role in ion and/or pro-
tein transport across membrane surfaces. Indeed, it has
been shown that recombinant bcl-2 and bcl-xl form
pores in liposomes and conductance channels in lipid
bilayers (Muchmore et al., 1996; Schendel et al., 1997;
Schlesinger et al., 1997). The formation of these chan-
nels occurs at acid pH and the resulting channels are
cation selective at physiological pH (Minn, 1997;
Schendel et al., 1997, 1997). The bcl-2 channel is selec-
tive for potassium while the bcl-xl channel conducts
sodium (Schendel et al., 1997, 1997; Lam et al., 1998).
The ability to form channels in vitro suggests that bcl-
2 and bcl-xl regulate the mitochondrial permeability
transition pore (PT) and release of proteins from the
mitochondrion, e.g., cytochrome c, that are critical to
the activation of cellular proteases (Boise and Thomp-
son, 1997; Decaudin et al., 1997; Kim et al., 1997;
Kitanaka et al., 1997; Kluck et al., 1997; Manon et al.,
1997; Vander Heiden et al., 1997; Yang et al., 1997a,
1997b; Bossy-Wetzel et al., 1998; Clem et al., 1998;
Zamzami et al., 1998; Finucane et al., 1999; Gross et
al., 1999).
The mitochondrial PT is a large (02.9 nm)
cyclosporin-sensitive channel present in the inner
mitochondrial membrane and opens during the pro-
cess of apoptotic cell death. The opening of this
channel has been associated with release of free
radicals, calcium and mitochondrial proteins critical
to caspase activation into the cytosol (Fig. 2; Ber-
Fig. 2. Regulation of the mitochondrial permeability transition pore (PT). (A) Bcl-2-bax or bcl-xl-bax heterodimers maintain the PT in a closed
state, preventing mitochondrial release of cytochrome c. Under conditions that lead to an increase in bax relative to bcl-2 or bcl-xl, bax homodi-
mers are formed (B). The bax homodimer alters the conformation of the PT allowing mitochondrial release of cytochrome c. Cytochrome c then
forms a trimeric complex with apaf-1 and procaspase-9. This complex cleaves procaspase-9 producing caspase-9 in the initial step of the mito-
chondrial-mediated caspase cascade.
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and bcl-xl have been localized to the outer mito-
chondrial membrane predominantly at sites of con-
tact between the inner and outer mitochondrial
membrane (Hockenbery et al., 1990). (bcl-2 and bcl-
xl prevent mitochondrial membrane depolarization
via the mitochondrial permeability transition in
apoptosis) (Fig. 2; Boise and Thompson, 1997; Dec-
audin et al., 1997; Kim et al., 1997; Kitanaka et
al., 1997; Kluck et al., 1997; Manon et al., 1997;
Vander Heiden et al., 1997; Yang et al., 1997a,
1997b; Bossy-Wetzel et al., 1998; Clem et al., 1998;
Zamzami et al., 1998; Finucane et al., 1999; Gross
et al., 1999). In addition, these proteins inhibit the
release of cytochrome c from the mitochondrion
and prevent the activation of caspases. The exact
mechanisms by which bcl-2 regulates the PT is yet
to be elucidated. Regulation of the PT by bcl-xl
occurs as a consequence of binding to the voltage-
dependent anion channel (VDAC) subunit of the
PT and subsequent closure of the VDAC (Shimizu
et al., 1998). bcl-xl may also interact with the ade-
nine nucleotide translocator (ANT) subunit of the
PT demonstrating that mitochondrial adenylate
transport is under active regulation. Furthermore,
bcl-xl expression allows cells to maintain sucient
mitochondrial ATP/ADP exchange to sustain
coupled respiration (Heiden et al., 1999), a mechan-
ism that may enable mitochondria to adapt to the
changes in metabolic demand during apoptotic cell
death.
Although the eects of bcl-2 and bcl-xl on mito-
chondrial permeability transition may be critical to its
regulation of cell survival during apoptosis, the pre-
sence of these proteins within other cell membranes
suggests that bcl-2 and bcl-xl have other apoptosis
regulatory functions (Hsu et al., 1997a, 1997b). Over-
expression of bcl-2 in vitro has been shown not only
to protect cells from oxidative agents but also to pre-
vent the generation of reactive oxygen species (Hock-
enbery et al., 1993; Kane et al., 1993; Satoh et al.,
1996; Wiedau-Pazos et al., 1996; Fabisiak et al., 1997)
in response to apoptotic stimuli. Bcl-2 has also been
shown to prevent apoptotic cell death associated with
increases in intracellular calcium (Zhong et al., 1993;
Distelhorst and McCormick, 1996; Marin et al., 1996;
Zormich, 1996; Ichimiya, 1998; Kruman et al., 1998)
by regulating intracellular calcium in several ways.
First, bcl-2 prevents depletion of intracellular calcium
from the endoplasmic reticulum (Lam et al., 1994; Dis-
telhorst and McCormick, 1996; He et al., 1997; Wei et
al., 1998) by enhancing calcium uptake (Kuo et al.,
1998). Second, bcl-2 overexpression potentiates the
uptake of calcium by mitochondria (Murphy et al.,
1996). Third, bcl-2 inhibits calcium entry into the
nucleus (Marin et al., 1996). There is also growing evi-
dence that bcl-2 may participate in intracellular pH
regulation. Intracellular acidi®cation is an important
event in the activation of endonucleases and cysteine
proteases during apoptosis (Barry and Eastman, 1992;
Perez-Sala et al., 1995; Morana et al., 1996; Furlong et
al., 1998). Intracellular acidi®cation-mediated caspase
activation has been shown to be prevented by overex-
pression of bcl-2 (Reynolds et al., 1996; Furlong et al.,
1997; Ishaque and Al-Rubeai, 1998). The speci®c
mechanism by which bcl-2 prevents intracellular acidi-
®cation is yet to be elucidated.
The presence of bcl-2 and bcl-xl within membranes
allows these proteins to serve as adapter proteins that
can sequester other proteins from the cytosol or facili-
tate protein±protein interactions as an alternate means
of regulating apoptotic pathways. Bcl-2 and bcl-xl
have been found to bind or co-immunoprecipitate with
a number of proteins including: ced-4 and its mamma-
lian equivalents, bax, raf-1, ras proteins, p53 binding
protein 2, Pr-1, and several other proteins of unknown
function (Sedlak et al., 1995; Sattler et al., 1997; Tao
et al., 1997; Gross et al., 1999; Holinger et al., 1999;
Weinmann et al., 1999). The C. elegans equivalent of
bcl-2, ced-9, has been shown to bind ced-4, thereby
inhibiting its action, i.e., caspase activation. Similarly,
bcl-2 and bcl-xl can complex with bax to form a het-
erodimer through binding at key residues within the
BH1 and BH2 domains and serving as an important
mechanism in regulating caspase activation (Yin et al.,
1994; Sedlak et al., 1995). Bcl-2 also associates with
the protein kinase, raf-1, pulling this protein from the
cytosol to the mitochondrial membrane (Wang et al.,
1996a, 1996b, 1996c). Once this association is formed,
raf-1 can phosphorylate the pro-apoptotic protein
BAD, nullifying its inhibition of the anti-apoptotic
actions of bcl-2. Bcl-2 has also been shown to seques-
ter the pro-apoptotic protein, calcineurin from the
cytosol, to intracellular membranes blocking apoptosis.
Formation of bcl-xl heterodimers with bax, bak, and
bid is an important process that prevents apoptotic
cell death by preventing activation of cysteine pro-
teases (Sedlak et al., 1995; Sattler et al., 1997; Tao et
al., 1997; Gross et al., 1999; Holinger et al., 1999;
Weinmann et al., 1999).
The presence of bcl-xl in the cytosol may also pre-
vent activation of proteases in other ways (Hsu et al.,
1997a, 1997b). Binding of bcl-xl to ced-4, its mamma-
lian homologue, Apaf-1, and to cytochrome c prevents
activation of the cysteine protease, caspase-9, an im-
portant step in the mitochondrial-mediated protease
cascade (Kharbanda et al., 1997; Li et al., 1997a;
1997b; Hu et al., 1998; Huang, 1998; Pan et al., 1998).
In addition, bcl-xl inhibits bax-mediated caspase acti-
vation by relocating bax from the mitochondrial mem-
brane to the cytosol (Priault et al., 1999). Bcl-xl also
interacts with the integral endoplasmic reticulum mem-
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caspase-8 by ced-4, an important step in the cytokine-
mediated protease cascade (Ng et al., 1997; Ng and
Shore, 1998).
In addition to apoptosis regulation, there is growing
evidence that bcl-2 also participates in regulation of
the cell cycle. Bcl-2 and bcl-xl have been shown to
maintain cells in a quiescent state (G0 phase of the cell
cycle; O'Reilly et al., 1996). The interaction of bcl-2
with calcineurin prevents the interaction of calcineurin
with the transcription factor, NF-AT, in its phos-
phorylated form, and subsequent translocation of NF-
AT into the nucleus (Linette et al., 1996; Shibasaki,
1997). Bcl-2 also inhibits the activation of cdk2, a
kinase responsible for the G0/G1 to S phase transition
of the cell cycle (Gil-Gomez et al., 1998).
6.2.2. Other Bcl-2 anti-apoptotic genes
Bag-1 is a protein that interacts with bcl-2 to block
apoptotic cell death (Wang et al., 1996a, 1996b, 1996c)
via several mechanisms. Binding of bag-1 to bcl-2 pre-
vents caspase activation (Schulz et al., 1997) and reac-
tive oxygen species generation. Bag-1 binding
facilitates bcl-2 activation of raf-1 kinase activity fol-
lowing the translocation of raf-1 to the mitochondrial
membrane (Wang et al., 1996a, 1996b, 1996c, 1999a,
1999b; Wang and Reed, 1998). The increased kinase
activity of raf-1 may be an important mechanism in
the phosphorylation/ deactivation of Bad or other re-
lated pro-apoptotic proteins (Wang et al., 1999a,
1999b). Bag-1 can also enhance protection from apop-
tosis binding to the platelet-derived growth factor
(PDGF) receptor (Bardelli et al., 1996). In addition,
Bag-1 stimulates the ATPase activity of the anti-apop-
totic chaperonins, Hsc70 and Hsp70 (Hohfeld and
Jentsch, 1997; Stuart et al., 1998).
Bax inhibitor 1 (BI-1) is found in intracellular mem-
branes and interacts with bcl-2 and bcl-xl to inhibit
bax-mediated apoptosis (Xu and Reed, 1998). B¯-1 is
a transcriptional target of NF-kappa B that inhibits
p53- and TNF-mediated apoptosis (D'Sa-Eipper et al.,
1996; Zong et al., 1999). B¯-1 also interacts with mul-
tiple oncogenes and, therefore, may be a regulator of
cell proliferation (D'Sa-Eipper and Chinnadurai,
1998). Boo inhibits apoptosis by forming a multimeric
protein complex with apaf-1 and caspase-9 (Song et
al., 1999). Bcl-w also promotes cell survival via
unknown mechanisms (Gibson et al., 1996).
The roles of bag-1, BI-1, and boo in neuronal apop-
tosis following hypoxia-ischemia have not yet been
established. In other systems, these proteins interact
with bcl-2 and bcl-xl to prevent caspase activation.
Because caspase activation is a process known to
occur in neurons undergoing apoptosis following hy-
poxia-ischemia (see below), it is therefore reasonable
to expect that bag-1, BI-1, and boo function to pre-
serve neuronal viability after such an insult. However,
data are lacking in this area.
6.2.3. Bax
Bax is one of the ®rst members of the bcl-2 family
found to promote apoptosis. To date, there are six
known isoforms of bax, all of which have been shown
to induce apoptosis (Oltvai et al., 1993; Apte et al.,
1995; Zhou et al., 1998; Shi et al., 1999). Bax has a
structure similar to that of bcl-2 and bcl-xl. Unique to
bax, however, is its ability to form oligomers but the
functional signi®cance of this biochemical property is
unknown (Tan et al., 1999). Like bcl-2 and bcl-xl, bax
forms membrane channels and binds to other bcl-2
family members, properties that are important to its
pro-apoptotic functions (Simonen et al., 1997). Bax
exists predominantly in the cytosol under unstressed
conditions but translocates to mitochondrial and other
membranes in response to apoptotic stimuli (Hsu et
al., 1997a, 1997b; Goping et al., 1998; Zhang et al.,
1998a, 1998b). Processing of bax by one or more cas-
pases appears to be necessary for this translocation
(Goping et al., 1998).
The membrane-associating property of bax led to
the observations that bax, like bcl-2 and bcl-xl, forms
ion channels in lipid bilayers (Antonsson et al., 1997).
These channels formed by bax are mildly chloride
selective, maximally active at acidic pH (Antonsson et
al., 1997; Schlesinger et al., 1997), and are antagonized
by bcl-2 (Antonsson et al., 1997). Bax also appears to
alter the intrinsic properties of lipid bilayers. Introduc-
tion of bax into phospholipid bilayers leads to destabi-
lization and rupture of membranes and their
subsequent breakdown (Basanez et al., 1999).
The translocation of bax to the mitochondrial mem-
brane and its destabilizing eect are important factors
that in¯uence mitochondrial function during apoptosis.
Once bax translocates to the mitochondrial membrane,
it cross-links as a homodimer leading to loss of mito-
chondrial membrane potential, cytochrome c release,
and caspase activation (Fig. 2; Eskes et al., 1998;
Gross et al., 1998; Jurgensmeier et al., 1998; Narita et
al., 1998; Saikumar et al., 1998; Finucane et al., 1999;
Priault et al., 1999). These mitochondrial changes
appear to occur via two mechanisms. First, cyto-
chrome c loss may occur via opening of the mitochon-
drial permeability transition pore in a process that is
calcium-dependent (Narita et al., 1998) and enhanced
by bax binding to the ANT subunit (Marzo et al.,
1998; Priault et al., 1999). The release of cytochrome c
through the permeability transition pore by bax
appears to require ATP and mitochondrial F1/F0
ATPase activity (Matsuyama et al., 1998; Narita et al.,
1998; Priault et al., 1999). Second, bax-dependent cyto-
chrome c release may also occur via a magnesium-
dependent mechanism (Eskes et al., 1998). The eects
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inhibited by both bcl-2 and bcl-xl as described above
(St. Clair et al., 1997; Zha and Reed, 1997; Jurgensme-
ier et al., 1998; Otter et al., 1998; Saikumar et al.,
1998; Priault et al., 1999).
The binding of bax to other members of the bcl-2
family is critical to its regulation of cell survival. The
formation of heterodimers versus homodimers is
dependent on the relative amounts of bax and bcl-2
and is important in regulation of caspase activity and
cell fate (Oltvai, 1997; Zha et al., 1997; Gross et al.,
1998; Otter et al., 1998; Perlman et al., 1999; Wein-
mann et al., 1999).
Bax may also function as a link between cell cycle
regulation and cell death. Bax inhibits activation of
cdk2, which is responsible for G0/G1 to S phase tran-
sition in the cell cycle (Gil-Gomez et al., 1998; Perlman
et al., 1998). In response to apoptotic stimuli, bax
causes actively dividing cells to enter a quiescent state
and subsequently undergo apoptosis in a process
mediated by the homeodomain protein gax (Perlman
et al., 1998).
6.2.4. Other Bcl-2 pro-apoptotic genes
Bak is a pro-apoptotic protein (Chittenden et al.,
1995a; Kiefer et al., 1995; Moss et al., 1996) whose ac-
tivity is mediated through its interaction with bcl-2-re-
lated proteins (Chittenden et al., 1995b; Sattler et al.,
1997). Bak forms heterodimers with both bcl-2 and
bcl-xl within mitochondrial membranes leading to
cytochrome c release and caspase activation
(McCarthy et al., 1997; Jurgensmeier et al., 1997; Mar-
tinou et al., 1998; Griths et al., 1999; Holinger et al.,
1999).
Bad promotes apoptosis via several mechanisms.
First, bad displaces bax from bcl-2 or bcl-xl heterodi-
mers, allowing free bax to carry out its death promot-
ing functions (Kelekar et al., 1997; Ottilie et al., 1997;
Yang et al., 1997a, 1997b; Zha et al., 1997). Formation
of heterodimers by bad may be prevented by phos-
phorylation (Zha et al., 1996; Scheid and Duronio,
1998; Zundel and Giaccia, 1998). In contrast, calcium-
activated protein phosphatase calcineurin dephosphor-
ylates bad, allowing it to translocate from the cytosol
to the mitochondrial membrane where it interacts with
bcl-xl (Fig. 1; Wang et al., 1999a, 1999b). Bad may
also induce apoptosis through mechanisms mediated
by ceramide (Basu et al., 1998).
Bid promotes apoptosis through its binding to bax
(Wang et al., 1996a, 1996b, 1996c). Bid is cleaved by
caspase-8 and the cleavage fragment translocates from
the cytosol to the mitochondrial membrane where it
induces a structural change in bax conformation lead-
ing to cytochrome c release (Li et al., 1998; Luo et al.,
1998; Gross et al., 1999).
Bim is a protein that appears to promote apoptosis
via binding to dynein light chains within microtubules
(O'Connor et al., 1998; Puthalakath et al., 1999). Diva
is a bcl-2 homologue that binds to Apaf-1 to induce
apoptosis (Inohara et al., 1998a). Bcl-xs is an m-RNA
splice variant of the bcl-x gene (Rouayrenc et al.,
1995; Grillot et al., 1997). The mechanisms by which
bcl-xs promotes cell death are yet to be elucidated.
Similarly, bik, blk, bod, bok, btf, harakiri, and mtd,
are proteins that interact with other bcl-2 family mem-
bers to promote apoptosis via unknown mechanisms
(Boyd et al., 1995; Elangovan and Chinnadurai, 1997;
Hsu et al., 1997a, 1997b; Inohara et al., 1997; Hegde
et al., 1998; Inohara et al., 1998b; Hsu et al., 1998;
Kasof et al., 1999).
The importance of these pro-apoptotic bcl-2 family
members in regulating neuronal apoptosis is yet to be
elucidated. However, based on their known mechan-
isms in other systems, bak, bad, bid, and diva are
likely to play a role in inducing neuronal death follow-
ing hypoxia- ischemia. For example, bak functions to
activate caspases in a manner similar to bax. Because
other members of the bcl-2 family have been shown to
have overlapping functions (e.g., bcl-2 and bcl-xl) in
regulating neuronal survival following hypoxia-ische-
mia, it is logical to predict that bak and bax may func-
tion similarly in promoting neuronal death. Also, bid
is an important mediator in cytokine-mediated apopto-
sis, a process that is known to contribute to neuronal
death following hypoxia-ischemia.
6.3. p53
The p53 gene and its protein product is likely the
most intensively studied tumor suppressor gene and is
the most commonly mutated gene in human cancers
(Hollstein et al., 1994). Under basal conditions, p53
exists at low concentration within cells and has a half-
life of 05±20 min (Levine, 1997; Giaccia and Kastan,
1998). The low concentrations of p53 appear to be the
consequence of mdm2-regulated ubiquitin-mediated
proteolysis (Haupt et al., 1997; Honda et al., 1997;
Kubbutat et al., 1997; Midgley and Lane, 1997). Fur-
thermore, the transcriptional activity of p53 is sup-
pressed under basal conditions by cytoplasmic
sequestration and by alteration of its phosphorylation
state (Moll et al., 1992; Moll et al., 1995; Knippschild
et al., 1997). In response to DNA damage, cellular
levels of p53 increase primarily because of an increase
in protein half-life from enhanced translation rather
than an increase in transcription (Maltzman and Czy-
zyk, 1984; Kastan et al., 1991; Price and Calderwood,
1993; Maki and Howley, 1997). In addition, p53 is
translocated to the nucleus where it transcriptionally
activates a number of target genes (Goldman et al.,
1996; Crook et al., 1998).
In addition to an increase in cellular concentration
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tional modi®cation critical for regulating its transcrip-
tional activity. P53 is phosphorylated on the serine
residues in both its amino- and carboxy- domains by a
number of protein kinases including casein kinases I
and II, protein kinase C, cdk2, and cdc2 (Bischo et
al., 1990; Lees-Miller et al., 1990; Baudier et al., 1992;
Milne et al., 1992; Hupp and Lane, 1994; Price et al.,
1995; Hall et al., 1996; Shieh et al., 1997). Phosphoryl-
ation of p53 enhances site selective binding of DNA
and therefore may regulate the dierences in transcrip-
tion of dierent p53 target genes (Wang et al., 1995;
Hecker et al., 1996). P53 DNA binding and transcrip-
tion are also enhanced by acetylation of p53 in its car-
boxy domain by members of the histone acetylase
family, p300/CPB (Avantaggiati et al., 1997; Gu and
Roeder, 1997; Lill et al., 1997; Scolnick et al., 1997).
There is new evidence demonstrating that the redox
state of p53 is also critical for p53 transcriptional ac-
tivity. First, oxidation of DNA causes loss of site-
speci®c DNA binding and binding of divalent cations
critical to p53 function (Hainaut and Milner, 1993a,
1993b; Delphin et al., 1994; Verhaegh et al., 1997).
Second, nitric oxide, a free radical generator, alters
p53 protein conformation and decreases p53 sequence
speci®c DNA binding (Calmels et al., 1997). Third, the
nuclear redox/repair protein, ref-1, reduces oxidized
p53, thus enhancing p53 DNA binding and its tran-
scriptional activity (Jayamaran et al., 1997).
Following its post-translational modi®cation, p53
transcriptionally activates a number of proteins
(Table 3) including bax (the bcl-2 family member),
insulin growth factor binding protein 3 (IGF-BP-3),
p21
WAF1/Cip1, cyclin G, GADD45, and mdm2 (Hansen
and Oren, 1997; Levine, 1997). These transcriptionally
activated proteins serve a number of functions includ-
ing induction of apoptosis, cell cycle regulation, DNA
repair, and autoregulation of p53. Bax is an important
but not the sole mediator of p53-dependent apoptosis
as, in some cases, overexpression of bax in the absence
of p53 fails to induce apoptosis (Myashita and Reed,
1995; Brady et al., 1996; see above). P53 may also
induce apoptosis through the actions of IGF-BP3
(Buckbinder et al., 1995; Ludwig et al., 1996; Ryan
and Vousden, 1998) which binds to the IGF receptor,
preventing IGF binding (Buckbinder et al., 1995).
Transactivation of p21
WAF1/Cip1 and GADD45 by
p53 leads to inhibition of cell cycle progression at the
G1/S transition phase (El-Deiry et al., 1993; Hollander
et al., 1993; Carrier et al., 1994). p21 inhibits cell cycle
progression by binding to cyclin-cdk complexes inhibit-
ing their kinase activity (Wu and Schonthal, 1997). In
contrast, GADD45 inhibits cell cycle progression at
the G1/S transition by binding to proliferating cell
nuclear antigen (PCNA). GADD45 also induces
growth arrest at the G2/M checkpoint through its ac-
tivity on the G2-speci®c kinase, cyclin B1/p34 (cdc2)
(Wang et al., 1999; Zhan et al., 1999).
GADD45 binding to PCNA is also important for
stimulating DNA excision repair (Kastan et al., 1992;
Smith et al., 1993; Hall et al., 1995). GADD45 binding
to PCNA is impaired by p21 binding to GADD45
(Kearsey et al., 1995) indicating that these two proteins
regulate PCNA in a competitive manner (Chen et al.,
1995a, 1995b). GADD45 may also function in DNA
excision repair by enhancing DNA relaxation and clea-
vage activity by topoisomerases, thereby facilitating
accessibility of DNase I to damaged DNA (Carrier et
al., 1999).
Transcriptional activation of mdm2 by p53 forms a
p53 autoregulatory feedback system that functions in
several ways. First, mdm2 binds to p53 targeting p53
for ubiquitin-mediated degradation (Haupt et al.,
1997; Honda et al., 1997; Kubbutat et al., 1997; Midg-
ley and Lane, 1997). Second, mdm2 enhances translo-
cation of p53 from the nucleus to the cytoplasm where
it is subjected to proteolysis (Roth et al., 1998). Third,
mdm2 binding to p53 inhibits transactivation of p53
downstream genes (Momand et al., 1992; Oliner et al.,
1993; Thut et al., 1997) in a process that is blocked by
phosphorylation of p53 (Shieh et al., 1997; Kamijo et
al., 1998; Pomerantz et al., 1998; Zhang et al., 1998a,
1998b; Zindy et al., 1998).
Although many of the functions of p53 occur via
transactivation of downstream genes, the eects of p53
on cellular functions also occurs via interactions with
other proteins (Tables 4 and 5). Following DNA
damage, for example, c-abl, an oncogene that func-
Table 3
Genes transactivated by p53
a
Gene Mechanism(s) of Action
bax Promotes mitochondrial permeability transition; promotes apoptosis
IGF-BP-3 Inhibits cellular mitogenic response; promotes apoptosis
p21
WAF1/Cip1 Binds to cyclin-cdk complexes; inhibits cell cycle progression
GADD45 Binds to PCNA; inhibits cell cycle progression; facilitates DNA repair
mdm2 Facilitates proteolytic degradation of p53; inhibits p53 transcriptional activity; faclitates p53 transport from nucleus to cytoplasm
a Hansen and Oren (1997), Levine (1997).
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tional activity resulting in growth arrest (Goga et al.,
1995). P53 also binds to the RNA polymerase II basal
transcription factor, TFIIH, that functions as a heli-
case and in DNA repair and transcription (Wang et
al., 1995). Cells de®cient in TFIIH helicase activity fail
to undergo apoptosis indicating that this interaction
may be the critical step in p53-mediated apoptosis
(Levine, 1997). The Wilms tumor suppressor gene pro-
duct, WT1, enhances p53 sequence-speci®c DNA bind-
ing and transcriptional activation but appears to
inhibit p53-mediated apoptosis (Maheswaran et al.,
1995)
6.4. Gene activation in hypoxia-induced apoptosis
Exposure of neurons to hypoxia induces changes in
immediate early genes, bcl-2 family members, p53, and
their downstream genes. Although the genetic mechan-
isms activated in neurons by hypoxic exposure are not
known in detail, a number of important observations
can be extracted from the current data. First, in re-
sponse to hypoxia, members of both anti-apoptotic
and pro-apoptotic genes families are expressed. It is
likely that the balance in the expression of these gene
families determines whether neurons will survive or
undergo apoptotic cell death following an hypoxic
insult. Those neurons, which undergo apoptosis in re-
sponse to hypoxia, tend to have a predominant ex-
pression of fosB, c-jun, NGFI-A, NGFI-C, p53, bax,
and bcl-xs while bcl-2, bcl-xl, and krox24 may be
unchanged, decreased, or increased (Shimazaki et al.,
1994; Krajewski et al., 1995; Hara et al., 1996; Dixon
et al., 1997; Li et al., 1997a, 1997b; Antonawich et al.,
1998; Rosenbaum et al., 1998; Joo et al., 1999). In
neurons surviving exposure to hypoxia, bcl-2, bcl-xl,
p21, and GADD45 expression predominates and im-
mediate-early gene expression is transient (Chen et al.,
1995a, 1995b, 1997; Lawrence, 1996, 1997; van Looke-
ren-Campagne and Gill, 1998a, 1998b; Guegan et al.,
1999). Measures to alter the balance in favor of anti-
apoptotic gene expression by hypoxic conditioning, by
genetic manipulation, or by attenuating pro-apoptotic
gene expression, have resulted in improved neuronal
Table 4
Proteins interacting with p53
a
Protein Mechanism(s) of action
c-abl Proto-oncogene; phosphorylates p53 enhancing p53 transcriptional activity
TFIIH Functions in DNA repair and transcription
WT1 Enhances p53 DNA binding and transcription; inhibits apoptosis
a Goga et al. (1995), Maheswaran et al. (1995), Levine (1997).
Table 5
Proteins targeted for proteolysis by caspases
a
Caspase Target protein Target protein function
Caspase-1 pro-interleukin 1b procaspase-3/4 Cytokine production proteases
Caspase-2 PARP DNA repair enzyme
Caspase-3 PARP
DNA protein kinases DNA repair enzyme
U1-70K sn ribonuclear proteins DNA repair
Hn ribonuclear protein-C pre-mRNA splicing
SREBP pre-mRNA splicing
D4-GDP dissociation inhibitor sterol biosynthesis





Caspase-6 lamins A, B, C1 nuclear cytoskeletal proteins
Caspase-7 PARP DNA repair enzyme
Hn-ribonuclear protein-C Pre-mRNA splicing
Caspase-8 Procaspases-3, -4, -7, -9 Proteases
Caspase-9 procaspase-3 protease
PARP DNA repair
Caspase-10 Procaspases-3 and -7 Proteases
a Nicholson and Thornberry (1997), Villa et al. (1997) Thornberry and Lazebnik (1998).
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Linnik et al., 1995; Meyer et al., 1995; Banasiak and
Haddad, 1998; Bossenmeyer-Pourie and Daval, 1998;
Kitagawa et al., 1998; Lawrence et al., 1998; Antona-
wich et al., 1999). In contrast, inhibiting anti-apoptotic
gene expression increases neuronal vulnerability to hy-
poxic injury (Banasiak et al., 1999).
Second, the relative expression of anti- and pro-
apoptotic genes may also account, in part, for regional
dierences in vulnerability to hypoxic insults. In brain
regions that are more sensitive to hypoxia, such as the
CA1 of the hippocampus, the Purkinje cell layer of the
cerebellum, amygdala, thalamus, striatum, and cortex,
persistent expression of junB, NGFI-A p53, bax, and
bcl-xs is predominant. In contrast, bcl-2, bcl-xl, and
krox24 expression may be unchanged or decreased
(Krajewski et al., 1995; Chen et al., 1996a, 1996b,
1997; Gillardon et al., 1996; Hara et al., 1996; Ferrer
et al., 1998; van Lookeren-Campagne and Gill, 1998a).
In contrast, those regions of the brain that are rela-
tively tolerant to hypoxic insults, such as CA3 and
dentate gyrus of the hippocampus, have preferential
expression of the protective genes bcl-2, bcl-xl, and
Gadd45 and only transient increases or no change in
immediate-early genes, p53 and bax (Chen et al.,
1996a, 1996b, 1998a). In addition, in regions more sus-
ceptible to hypoxic injury, there is transcription but
not translation of IEGs and other survival promoting
genes (Hughes et al., 1998).
Third, the severity of the hypoxic insult not only in-
¯uences the form of neuronal cell death that occurs
but also the pattern of gene expression. With pro-
longed ischemic insults or in central regions of the
infarct zone, where oxygen levels are exceedingly low,
necrotic cell death predominates (Linnik et al., 1993;
Beilharz, 1995; Hill et al., 1995; Li et al., 1995). Under
these conditions in vivo, bax and p53 levels are
increased while bcl-2, bcl-xl, and GADD45 are
decreased (Jin et al., 1996; Hou et al., 1997; Chen et
al., 1998a; Ferrer et al., 1998; Isenmann et al., 1998;
Matsushita et al., 1998; van Lookeren-Campagne and
Gill, 1998a; van Lookeren-Campagne and Gill, 1998b).
Similarly, in vitro studies of prolonged hypoxic ex-
posure resulting in neuronal death have shown that
bax and p53 are increased while bcl-2 may be
increased or decreased (Shimazaki et al., 1994; Ferrer
et al., 1997; Niwa et al., 1997; Banasiak and Haddad,
1998; Bossenmeyer-Pourie and Daval, 1998; Tamatani
et al., 1998; Banasiak et al., 1999).
In contrast, in the penumbral region, where oxygen
levels may be graded, both apoptotic and necrotic cell
death are detectable (Linnik et al., 1993; Beilharz,
1995; Hill et al., 1995; Li et al., 1995). In the penum-
bral region, bcl-2, bcl-xl, p21, and GADD45 ex-
pression is increased while bax and p53 expression is
decreased (Chen et al., 1995a, 1995b, 1998a; Hou et
al., 1997; Antonawich et al., 1998; Isenmann et al.,
1998; van Lookeren-Campagne and Gill, 1998b). Simi-
larly, exposure to brief periods of hypoxia in vitro has
been associated with upregulation of bcl-2 and c-jun
resulting in improved neuronal survival to subsequent
insults (Shimazaki et al., 1994; Bossenmeyer-Pourie
and Daval, 1998; Whit®eld et al., 1999).
Fourth, gene expression may be altered in regions of
the brain well beyond the boundary of the infarct zone
and penumbra. In models on unilateral focal hypoxia-
ischemia, transient increases in c-fos, fosB, c-jun, Jun
B, junD, NGFI-A, NGFI-B, NGFI-C, egr-2, egr-3,
krox20, krox24, and Nurr1 have been detected in areas
of the cortex outside of the infarct zone extending to
the contralateral hemisphere (Gubits et al., 1993; Dra-
gunow et al., 1994; Kinouchi et al., 1994; Lin et al.,
1996; Honkaniemi et al., 1997). These and other data
seem to support the hypothesis that spreading de-
pression, resulting from excitatory amino acid release
and other consequences of ischemic injury, may in¯u-
ence gene activation in regions unaected by the
ischemic lesion. The glutamate receptor antagonists,
MK801 and dextromethorphan, have been shown to
attenuate c-jun, and c-fos expression and improve
neuronal survival following hypoxia-ischemia (Gass et
al., 1992; Bokesch et al., 1994; Collaco-Moraes et al.,
1994). Increased intracellular calcium, resulting from
glutamate or inositol triphosphate receptor activation,
is a potent inducer of IEG transcription (Graybiel et
al., 1990). Neurotrophic factors and cytokines, such as
FGF-2, TGF-1, and IL-1, activated during hypoxia-
ischemia, have been shown to induce c-fos expression.
The consequences of immediate-early gene induction in
these ``unaected'' regions is still to be determined.
Fifth, p53 activates both pro-apoptotic as well as
survival mechanisms in response to hypoxic insults.
Whether apoptosis or survival will occur seems to be
dependent on the duration of p53 and downstream
gene expression. Following an ischemic insult, a transi-
ent rise in p53 with persistence of p21 and GADD45
expression correlates with improved survival in CA3
hippocampal neurons (Tomasevic et al., 1999). It is
possible that p21 may confer protection by preventing
quiescent cells from entering the cell cycle and allowing
for DNA repair by GADD45 and other proteins. In
contrast, CA1 hippocampal neurons exhibit persist-
ently elevated levels of p53 and more widespread apop-
totic death (van Lookeren-Campagne and Gill, 1998a).
Despite the growing knowledge of gene activation,
the exact trigger for induction of p53 and other genes
during hypoxia is unclear. There is equivocal evidence
that DNA strand breaks lead to increased cellular p53
(Stoler et al., 1992; Graeber et al., 1994; Banasiak and
Haddad, 1998). There is also no evidence to support
the idea that p53 and bcl-2 accumulate during hypoxia
as a result of a stress-induced increase in protein syn-
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Sutherland, 1986; Petterson et al., 1986; Banasiak and
Haddad, 1998; Banasiak et al., 1999). However, there
is now evidence to suggest that hypoxia induces phos-
phorylation and consequent stabilization of p53 (Giac-
cia and Kastan, 1998). Also, redox sensitive proteins,
such as HIF 1, contribute to accumulation and sub-
sequent stabilization of p53 and reduction of bcl-2
during hypoxic exposure (An et al., 1998; Carmeliet et
al., 1998). The protein products of the downstream
genes, GADD 45 and p21, are also increased in re-
sponse to hypoxia via mechanisms that are HIF 1-
independent and dependent (Price and Calderwood,
1992; Long et al., 1997; Carmeliet et al., 1998). One
must consider that hypoxia may not directly alter gene
activity but rather biochemical events consequent to
hypoxic exposure, such as altered ionic homeostasis or
energy depletion, may alter gene expression during
apoptosis.
7. Caspases and cytokines
During the process of apoptosis, there are a number
of biochemical events that are critical to the ultimate
degradation of the cell. One of these events is the acti-
vation of proteolytic enzymes, the cysteine proteases or
caspases. The role of caspases in apoptotic cell death
was realized with the discovery of Ced-3, a requisite
cell death gene in Caenorhabditic elegans homologous
to mammalian interleukin-1-b-converting enzyme
(ICE; caspase 1) (Thornberry et al., 1992; Yuan et al.,
1993). Although, caspase-1 has no clear role in mam-
mals, its discovery led to the identi®cation of a
cysteine protease cascade integral to apoptotic cell
death. In this section, these proteolytic cascades and
their regulation will be discussed.
7.1. Chemical properties of caspases
Caspases are all expressed as proenzymes (30±50
kD) containing three subunits: an NH2-terminal
domain, a large subunit (20 kD), and a small subunit
(10 kD) (Nicholson and Thornberry, 1997). Caspases
are activated following proteolytic processing and as-
sociation of the large and small subunits (Walker et
al., 1994a, 1994b; Wilson et al., 1994; Rotonda et al.,
1995). The proenzyme structure has inherent properties
critical to the activation of these molecules. First, the
NH2-terminal domain acts as a recognition site for ac-
tivation (Thornberry and Lazebnik, 1998). Second,
cleavage of the proenzyme occurs at consensus sites in-
dicating that caspase activation may occur autocataly-
tically or in a cascade (Thornberry and Lazebnik,
1998).
Once activated, caspases cleave proteins in a rela-
tively substrate speci®c manner. The substrate speci-
®city and catalytic eciency of caspases stems from
recognition of at least four amino acids NH2-terminal
to the cleavage site (Thornberry et al., 1997). The sub-
strates targeted by the caspases are proteins that are
vital to cell viability (Cryns and Yuan, 1998). These
include: DNA repair proteins (e.g., DNA-protein
kinase), negative regulators of apoptosis (e.g., bcl-2),
and structural proteins (e.g., nuclear lamina, cyto-
skeletal proteins) (Orth et al., 1996; Takahashi et al.,
1996; Cheng et al., 1997; Kothakota et al., 1997;
Rheaume et al., 1997; Rudel and Bokoch, 1997; Wen
et al., 1997; Xu and Reed, 1998; Adams and Cory,
1998). The proteolytic activities of the caspases on
these substrates provide mechanism for the morpho-
logic changes observed in cells during apoptotic cell
death. Regulation of caspase activity by bcl-2 family
proteins is discussed above.
7.2. Regulation of caspases
7.2.1. Cytokine-mediated caspase activation
There is a large body of evidence supporting the
existence of a cysteine protease cascade with initiator
and eector caspases. To date, caspase-3 can be acti-
vated via two mechanisms: (a) via cytokine-mediated
receptor activation and (b) via alteration of mitochon-
drial membrane potential (Fig. 3). Currently, four cas-
cades leading to caspase activation in response to
apoptotic stimuli are known. The ®rst involves death
receptor mediated activation of caspase-8 (Fig. 5; Ash-
kenazi and Dixit, 1998). The second cascade is charac-
terized by activation of caspase-9 by cytotoxic agents
Fig. 3. Mechanisms of activation of caspase-3. Caspase-3 can be acti-
vated by either of two mechanisms: (a) via cytokine-mediated recep-
tor activation or (b) mitochondrial release of cytochrome c through
the permeability transition pore. Binding of fas or TNF-a leads to
activation of caspase-8, which, in turn, cleaves procaspase-3, yielding
activated caspase-3. Alternatively, mitochondrial release of cyto-
chrome c leads to activation of caspase-9 that, in turn, activates cas-
pase-3.
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al., 1998). The other two are less well characterized
and involve binding of Apo3 ligand (TWEAK) and
Apo2 ligand (TRAIL) to the tumor necrosis factor
receptor (TNFR) family members DR3, DR4, and
DR5 (Wiley et al., 1995; Marsters et al., 1996; Chiche-
portiche et al., 1997; McFarlane et al., 1997; Pan et
al., 1997a, 1997b; Screaton et al., 1997; Schneider et
al., 1997; Sheridan et al., 1997; Walczak et al., 1997;
Marsters et al., 1998).
Activation of caspase-8 may occur through binding
to Fas (also known as CD95 or Apo1), TNFR1, or
DR3 (Nagata, 1997). The Fas receptor is a homotri-
meric molecule with an adapter protein termed the
Fas-associated death domain (FADD) (Fig. 4; Chin-
naiyan et al., 1995). Within FADD, a death eector
domain (DED) binds to an analogous domain of the
proenzyme form of caspase-8 (Boldin et al., 1996). Fol-
lowing its interaction with DED, caspase-8 becomes
activated through self-cleavage (Chinnaiyan et al.,
1996; Hsu et al., 1996a, 1996b; Muzio et al., 1998).
The active form of caspase-8 then proteolytically acti-
vates downstream caspases ultimately leading to the
activation of the eector protease, caspase-3 (Li et al.,
1997a, 1997b; Muzio et al., 1998).
Activation of caspase-8 may also occur through
receptor binding of TNFR1 (also known as p55 or
CD120a; Fig. 4; Ashkenazi and Dixit, 1998). TNF-
mediated caspase activation occurs subsequent to as-
sociation of the TNFR1 death domains and sub-
sequent binding of an adapter termed TNFR-
associated death domain (TRADD) (Hsu et al.,
1996a). TRADD functions as a docking protein for a
number of signaling molecules including FADD,
TNFR-associated factor-2 (TRAF-2), and receptor
interacting protein (RIP) (Rothe et al., 1995; Hsu et
al., 1996a). FADD mediates activation of caspase-8 as
described above. In contrast, TRAF-2 and RIP stimu-
Fig. 4. Mechanisms of fas and TNF-a receptor caspase activation. (A) Binding of fas to its receptor leads to caspase-8 activation via procaspase-
8 interaction with the fas-associated death domain (FADD). Activated caspase-8 cleaves caspase-3 to its activated form leading to subsequent
apoptotic cell death. (B) Binding of TNF-a to its receptor also leads to caspase-8 activation via procaspase-8 interaction with the TNF-receptor
and fas-associated death domains (TRADD and FADD). Alternatively, TNF-receptor binding may lead to activation of the nuclear transcription
factor KB (NF-?B) and jun kinases forming pathways that inhibit apoptosis.
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NF-kappa B and Jun kinase/AP1 (Rothe et al., 1995;
Hsu et al., 1996a, 1996b).
The DR3 receptor exhibits close sequence homology
with the TNFR1 receptor (Pan et al., 1997a). Upon
binding of Apo3 ligand, the DR3 receptor can activate
caspase-8 or inhibit apoptotis via mechanisms similar
to that of TNFR1 (Chicheportiche et al., 1997; Mar-
sters et al., 1998). It is unlikely that DR3 is important
in neuronal apoptotic cell death as it is predominantly
expressed in the spleen, thymus, and the peripheral
blood (Tartaglia and Goeddel, 1992; Pan et al.,
1997a).
Caspase activation leading to apoptotic cell death
may also occur via binding of Apo2 ligand (TRAIL)
to DR4 or DR5 TNF family receptors (Marsters et
al., 1996; Mariani et al., 1997; Martinez-Lorenzo et al.,
1998). The mechanism by which binding of these
receptors induces caspase activation is unclear. There
is con¯icting evidence as to whether these receptors
interact with adapter molecules, such as FADD,
TRADD, TRAF2, or RIP (Pan et al., 1997a, 1997b;
Walczak et al., 1997; Schneider et al., 1997). However,
there is evidence that DR4 may induce apoptosis via a
FADD-independent pathway (Yeh et al., 1998).
7.2.2. Cytotoxic caspase activation
Caspase-3 activation also occurs in a manner that is
independent of caspase-8 activation (Fig. 3; see above).
Following mitochondrial release of cytochrome c in re-
sponse to cytotoxic stimuli, cytochrome c forms a tri-
meric complex with apoptosis protease activating
factor-1 (Apaf-1), and the proenzyme form of caspase-
9 (Li et al., 1997a, 1997b). The resulting complex
cleaves and activates caspase-9 that then is available to
activate caspase-3 (Li et al., 1997a, 1997b).
7.3. Role of cytokines and caspases in hypoxia-induced
apoptosis
There is a vast body of literature documenting an
increase in cytokines following hypoxic-ischemic injury
(Stoll et al., 1998). TNF-a, fas, TRAIL, and TNFR1
are increased in brain and spinal cord following an hy-
poxic-ischemic insult and correlate with the occurrence
of apoptosis (Matsuyama et al., 1994, 1995; Botchinka
et al., 1997; Sairanen et al., 1997; Chao et al., 1998;
Sakurai et al., 1998; Zhai et al., 1997; Herr et al.,
1999; Martin-Villalba et al., 1999). However, some
controversy exists as to whether cytokine release, par-
ticularly TNF-a, enhances neuronal injury or promotes
neuronal survival. The majority of in vivo studies
demonstrate the detrimental eects of TNF-a. Admin-
istration of TNF-a enlarges infarct size while TNFR1
receptor blockers and TNF antibodies reduce infarct
size (Barone et al., 1997; Meistrell et al., 1997; Nawa-
shiro et al., 1997; Lavine et al., 1998; Yang et al.,
1998; Herr et al., 1999). Apoptosis induced by these
death-inducing ligands has been attributed to ceramide
and nitric oxide generation and caspase activation
(Nomura, 1998; Herr et al., 1999). In contrast, data
exist supporting a protective eect of TNF-a.T N F - a,
for example, has been shown to prevent neuronal
apoptosis in vivo and in vitro (Tamatani et al., 1999).
Furthermore, mice lacking TNFR1 (p55) have
increased damage in response to hypoxic-ischemic
injury compared to wild-type controls (Gary et al.,
1998). TNF-a may exert its protective eects via NF-
kappaB mediated activation of bcl-2 and bcl-xl ex-
pression (Tamatani et al., 1999). There is no clear
answer as to why TNF-a possesses these two opposing
eects. One possible explanation may be that persist-
ent, expression of NF-kappaB induced by TNF-a pro-
motes neuronal apoptosis while transient elevations of
NF-kappa B have been associated with neuronal survi-
val (Clemens et al., 1997a, 1997b). Another possibility
is that TNF-a may be acting on dierent receptors,
although there is no clear evidence currently to sup-
port this hypothesis.
It is becoming clearer that caspases are likely the
critical eector molecules in hypoxia-induced apopto-
sis. Activation of caspase-3 has been shown in apopto-
tic cells following hypoxic insults (Chen et al., 1998b;
Namura et al., 1998; Pulera et al., 1998; Schulz et al.,
1998; Tamatani et al., 1998). Inhibitors of caspase-3
have shown some protective eect against hypoxic
neuronal injury (Cheng et al., 1998; Nath et al., 1998;
Tamatani et al., 1998). Current evidence suggests that
both cytokine receptor activation and mitochondrial
permeability transition contribute to the activation of
caspase-3 during cerebral hypoxia-ischemia.
Caspases contribute to the genesis of apoptosis
(Table 3) by: (a) activation of caspases and other
death promoting agents, (b) destruction of cytoskeletal
elements, and (c) inactivation of anti-apoptotic pro-
teins. For example, caspase-3 is converted from its
inactive, or procaspase, form by caspase-8 following
Fas receptor activation (Muzio et al., 1997; Takahashi
et al., 1997). Similarly, following mitochondrial cyto-
chrome c release and caspase-9 activation, the acti-
vated form of caspase-9 cleaves procaspase-3,
producing activated caspase-3 (Li et al., 1998). The
activated form of caspase-3 targets multiple proteins
for proteolysis. Actin is a cytoskeletal protein shown
to be cleaved by caspase-3, a mechanism that may be
important to the structural changes observed in apop-
totic cells (Villa et al., 1997; Thornberry and Lazebnik,
1998). Caspase-3 has been also shown to cleave the
anti-apoptotic protein, bcl-2, releasing a fragment that
promotes apoptosis (Cheng et al., 1997; Xue and Hor-
vitz, 1997; Adams and Cory, 1998). Determination of
the exact pathway(s) leading to caspase activation in
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However, it is likely that both cytokine- mediated and
cytotoxic-mediated mechanisms will be involved.
8. Future directions
Hypoxia-induced neuronal apoptosis involves an
ever-growing broad range of biochemical and gen-
etic mechanisms. Despite the eorts by numerous
investigators, most of our knowledge in this area
remains descriptive. Clearly, these studies are im-
portant but many important questions regarding the
functions of genes, proteins, and other mechanisms
in determining cell survival or death following hy-
poxia-ischemia remain unanswered.
Based on current studies, there are a number of
areas of great interest regarding the mechanisms indu-
cing apoptosis in response to hypoxia.
1. Does hypoxia directly induce apoptosis in neurons?
Current evidence seems to suggest that hypoxia, in
and of itself, does not induce apoptosis. The possi-
bilities of energy depletion, or altered ionic homeo-
stasis, or ``oxygen-sensing'' molecules as the
initiating events should be pursued further.
2. What is the role of altered ionic homeostasis, par-
ticularly potassium and sodium, in neuronal apop-
tosis and through what channel or transporter does
the ¯ux take place? There is strong evidence sup-
porting the relationship between changes in ionic
¯ux and apoptosis. Increases in intracellular calcium
have been linked with gene activation. As it has
been recently observed, it is possible to consider
that changes in intracellular sodium and potassium
may play similar roles.
3. What is the role of altered intracellular pH in apop-
tosis? Current evidence links decreased intracellular
pH with caspase and endonuclease activation, a
process that can be abrogated by intracellular alka-
lization. With growing evidence that other cations
may alter gene expression, the possibility that
changes in intracellular pH may do so as well does
not seem improbable.
4. What is the role of immediate-early genes and re-
lated transcription factors in hypoxia-induced apop-
tosis? The varied expressions of these genes may
impact on neuronal survival. Which of these genes
promote and which inhibit apoptosis remains
unclear. In addition, the downstream genes acti-
vated by the IEGs require further investigation.
5. What are the mechanisms controlling the dierences
in gene expression in regions of the brain more sus-
ceptible to injury from hypoxia versus regions resist-
ant to hypoxic injury?
6. What is the role of altered gene expression in
regions of the brain outside those regions supplied
by an occluded blood vessel?
7. What are the conditions that determine whether
cytokines contribute to further neuronal death or
neuronal survival following hypoxic-ischemic injury?
8. What is the functional importance of apoptotic
neuronal death following hypoxia-ischemia? It is
generally accepted that apoptosis contributes to an
increase in infarct size. The question that remains is
whether inhibition of neuronal apoptosis following
hypoxia-ischemia will contribute to improved neuro-
logic outcome.
9. What are some of the speci®c markers of apoptosis?
Can we develop methods to delineate apoptosis in a
better fashion than we have at present, keeping in
mind the new knowledge that is forthcoming?
10. What are some of the pharmacological interven-
tions that are potentially helpful in interrupting
apoptosis? What are some of the key steps that
could be used in gene targeting or experimental or
therapeutic designs to alleviate cell death?
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